Global Pharmatech Pvt. Ltd. (GPPL), a Sterile Injectables Company, started operations in 1996 that manufactures high quality liquid sterile formulations in small volume glass vials and ampoules, and large volume glass bottles. With a strong commitment to Quality and Compliance, GPPL has built a reputation in the industry for quality and reliability. The facility is capable of manufacturing both aseptically filled and terminally sterilized products.
GPPL has EU-GMP (Hungary), Health Canada, PIC/S, NAFDAC, ZAZIBONA, WHO-GMP, ISO 9001. GPPL is registering products to trigger US-FDA approvals.
With two decades of experience in Sterile Manufacturing, we have in-house capabilities to perform end to end integrated pharmaceutical development and manufacturing ranging from literature search, formulation development, analytical methods development and validation, stability studies, global regulatory management, cGMP manufacturing till supply of commercial sterile injectables products.
Global Pharmatech facility spreads across a 5 acres plot, in Hosur, Tamil Nadu (outskirts of Bangalore) with a 5,000 SqFT injectables R&D facility. The manufacturing unit consists of an integrated ampoule line and an integrated glass vial line.
In the last few years, GPPL is truly evolved as a prominent injectables manufacturer by leveraging India cost advantage and scientific talents and by following stringent quality systems.
We have the technical expertise, agility, talent and drive to achieve our vision. In our journey to achieve this vision, our relationship with our customers is far more than just business-- it is a partnership with the objective of achieving successful business outcomes based on trust and commitment, and collaborative approach to deliver products and services to our customers exceeding their expectations.
Dr. Bhaskar Krishna Arumugam
Dr. Bhaskar Krishna has been the Managing Director of Global Pharmatech since May 2013. Earlier, Bhaskar was the CEO of Granules India Limited (GIL), a vertically integrated Pharmaceutical company. Under Bhaskar’s leadership, the company grew at 27% CAGR, growing from revenue of Rs. 200 cr ($40 M, 2007) to Rs. 750 cr ($150 M, 2013).
Prior to joining GIL, Bhaskar spent 11 years at Eastman Chemical Company, a USD 7B corporation in various functions such as R&D, strategy, business development, and manufacturing. During this period, Bhaskar worked on nutraceuticals, advanced materials, and specialty chemicals.
Bhaskar has a B Tech (Chemical) from IIT-Madras, PhD (Chemical) from Purdue, and MBA (General Management) from Duke University. Bhaskar has eight patents and numerous publications and presentations to his credit.
Dr. Bhaskar Krishna Arumugam
Dr. Bhaskar Krishna has been the Managing Director of Global Pharmatech since May 2013. Earlier, Bhaskar was the CEO of Granules India Limited (GIL), a vertically integrated Pharmaceutical company. Bhaskar led the transformation of Granules India Limited (GIL) growing GIL from revenues of Rs.200cr ($40 M, 2007) to Rs.750cr ($150 M, 2013). Prior to joining GIL, Bhaskar spent 11 years at Eastman Chemical Company (USA), a USD 7B corporation in various functions such as R&D, strategy, business development, and manufacturing.
Bhaskar has a B Tech (Chemical) from IIT-Madras, PhD (Chemical) from Purdue, and MBA from Duke University. Bhaskar has eight patents and numerous publications and presentations to his credit.
Finance & HR
Mr. Shivananda has 15 years of finance experience across various industries. He joined GPPL in 2007 as Financial Controller, taking additional charge of Company Secretarial work from 2010 and Human Resource function from 2013. Previously, he was CFO at Devon Innovations which included Devon Innovations’ orthopedic division, Ormed Medical Technology. Prior to that, he was Manager – Finance at Mysore Sugar Company Limited.
Shivananda holds a degree in commerce and is a qualified Chartered Accountant and Company Secretary.
Approvals and Certifications